Company intelligence / Profile preview

MENADNA Inc.

United Arab Emirates

Ownership: Private
Development stage: Other

Overview

MENADNA offers consumer-based personalized genetic and health reports based on genome analysis, including region-specific insights for the Middle East and North Africa (MENA). The offering includes advanced whole genome sequencing in partnership with Nebula Genomics, targeting improved genomic research and healthcare delivery in the region. No clinical therapeutic trials are reported; reports are for informational and educational purposes only[1][2][5][7][8].

Industry: Molecular Diagnostics

Partnerships

Nebula Genomics

Beyond the preview

Go deeper on MENADNA Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MENADNA Inc..

Explore the full profile